PSI Journal Club: Limitations and Challenges with Mixed Model Repeated Measures (MMRM) Analysis
Moses Mwangi and Florian Lasch present their recent work on MMRM, with discussion lead by Geert Molenberghs.
Chair: Katherine Hutchinson: PSI Vice-Chair & Membership Secretary, Quanticate
Speaker: Richard Kay: RK Statistics Ltd, Great Longstone, UK
On assessing the presence of evaluation-time bias in progression-free survival in randomized trials
Co-authors: Jane Wu, Janet Wittes
Published Online: Jun 21 2010
(Subsequently published in: Pharmaceutical Statistics, Volume 10, Issue 3, pages 213–217, May/June 2011)
Abstract | Paper+ | Slides
Speaker: Gui-shuang Ying: Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Weibull prediction of event times in clinical trials
Co-author: Daniel F. Heitjan
Pharmaceutical Statistics, Volume 7, Issue 2, pages 107-120, April/June 2008
Abstract | Paper+ | Slides
+ Papers available to view from 20th October 2010 to 17th November 2010.
For a flier advertising the event, please click here.
Moses Mwangi and Florian Lasch present their recent work on MMRM, with discussion lead by Geert Molenberghs.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Talks from speakers will cover an introduction to HTA and indirect comparisons for value assessment before focusing in more specifically on topics related to the use of indirect treatment comparisons for patient access.
Talks from the speakers will cover the use of R in a programming community, submitted to regulators using R, and also programming beyond R in C++ and Julia.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.